Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-derived organoids identify an apico-basolateral polarity switch associated with survival in colorectal cancer.
Canet-Jourdan C, Pagès DL, Nguyen-Vigouroux C, Cartry J, Zajac O, Desterke C, Lopez JB, Gutierrez-Mateyron E, Signolle N, Adam J, Raingeaud J, Polrot M, Gonin P, Mathieu JRR, Souquere S, Pierron G, Gelli M, Dartigues P, Ducreux M, Barresi V, Jaulin F. Canet-Jourdan C, et al. Among authors: gelli m. J Cell Sci. 2022 Jul 15;135(14):jcs259256. doi: 10.1242/jcs.259256. Epub 2022 Jul 25. J Cell Sci. 2022. PMID: 35703098
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
Valery M, Cervantes B, Samaha R, Gelli M, Smolenschi C, Fuerea A, Tselikas L, Klotz-Prieux C, Hollebecque A, Boige V, Ducreux M. Valery M, et al. Among authors: gelli m. Cancers (Basel). 2022 Sep 19;14(18):4523. doi: 10.3390/cancers14184523. Cancers (Basel). 2022. PMID: 36139683 Free PMC article. Review.
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F. Roy P, et al. Among authors: gelli m. Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11. Int J Pharm. 2017. PMID: 28803938
Molecular targeted therapy of BRAF-mutant colorectal cancer.
Ducreux M, Chamseddine A, Laurent-Puig P, Smolenschi C, Hollebecque A, Dartigues P, Samallin E, Boige V, Malka D, Gelli M. Ducreux M, et al. Among authors: gelli m. Ther Adv Med Oncol. 2019 Jun 18;11:1758835919856494. doi: 10.1177/1758835919856494. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31244912 Free PMC article. Review.
Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience.
Touloupas C, Faron M, Hadoux J, Deschamps F, Roux C, Ronot M, Yevich S, Joskin J, Gelli M, Barbé R, Lamartina L, Tissot H, Scoazec JY, Malka D, Ducreux M, Baudin E, de Baère T, Tselikas L. Touloupas C, et al. Among authors: gelli m. Cancers (Basel). 2021 Oct 26;13(21):5366. doi: 10.3390/cancers13215366. Cancers (Basel). 2021. PMID: 34771531 Free PMC article.
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D. Goéré D, et al. Among authors: gelli m. BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7. BMC Cancer. 2018. PMID: 30081865 Free PMC article.
150 results